A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Clinical trial NCT04032704 · TERMINATED

Trial details

NCT number: NCT04032704
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Non-small Cell Lung Cancer, Squamous Non-small Cell Lung Cancer, Non-squamous Head and Neck Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Prostate Cancer Melanoma

Start date: 2019-10-09
Primary completion: 2023-11-28
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.